BioRestorative Therapies (BRTX) stock price, revenue, and financials

BioRestorative Therapies market cap is $10.4 m, and annual revenue was $111 k in FY 2018

$10.4 M

BRTX Mkt cap, 08-Oct-2018

$31 K

BioRestorative Therapies Revenue Q2, 2019
BioRestorative Therapies Net income (Q2, 2019)-4.2 M
BioRestorative Therapies EBIT (Q2, 2019)-2.1 M
BioRestorative Therapies Cash, 30-Jun-20191.3 M

BioRestorative Therapies Income Statement

Annual

USDFY, 2013FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.7k1.7k416.0k628.9k36.4k81.0k111.0k

Revenue growth, %

24662%51%(94%)

Cost of goods sold

208.0208.0213.8k261.5k102.0

Gross profit

1.5k1.5k202.2k367.4k36.3k

Gross profit Margin, %

88%88%49%58%100%

Sales and marketing expense

1.4m

R&D expense

1.6m1.4m2.1m2.9m2.2m1.5m

General and administrative expense

2.3m2.3m3.9m3.3m3.9m4.0m

Operating expense total

4.8m5.1m7.5m7.8m8.5m7.8m

EBIT

(4.8m)(4.8m)(4.9m)(7.2m)(7.8m)(8.4m)(7.6m)

EBIT margin, %

(282873%)(282873%)(1183%)(1140%)(21448%)(10339%)(6890%)

Interest expense

371.3k371.3k285.3k263.6k221.6k468.1k932.2k

Net Income

(5.8m)(5.8m)(5.6m)(7.9m)(8.6m)(9.4m)(12.5m)

BioRestorative Therapies Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

201.1k91.8k166.6k31.8k451.7k117.5k

Accounts Receivable

93.4k6.0k38.0k29.0k

Inventories

18.0k1.9k29.3k

Current Assets

239.8k114.3k289.3k61.7k519.7k181.0k

PP&E

35.6k493.9k643.1k508.6k327.8k175.2k

Total Assets

1.4m1.7m2.0m1.6m1.8m1.2m

Accounts Payable

1.3m1.1m2.5m2.3m2.5m1.9m

Short-term debt

Current Liabilities

7.5m8.5m5.6m5.8m8.4m9.3m

Long-term debt

Total Debt

Total Liabilities

8.1m5.9m6.6m8.6m9.8m

Additional Paid-in Capital

13.1m18.5m29.4m37.0m44.6m55.3m

Retained Earnings

(25.4m)(33.3m)(42.0m)(51.4m)(63.9m)

Total Equity

(6.7m)(6.9m)(3.9m)(5.0m)(8.6m)

Financial Leverage

-0.2 x-0.2 x-0.5 x-0.3 x-0.1 x

BioRestorative Therapies Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(5.8m)(5.6m)(7.9m)(8.6m)(9.4m)(12.5m)

Depreciation and Amortization

104.8k96.7k213.8k258.4k259.3k240.4k

Accounts Receivable

(93.4k)87.4k(32.0k)9.0k

Inventories

(5.5k)613.0(6.8k)

Accounts Payable

498.5k(234.6k)1.4m(113.2k)186.0k(516.1k)

Cash From Operating Activities

(2.7m)(3.2m)(3.1m)(5.0m)(3.9m)(5.1m)

Purchases of PP&E

(11.2k)(168.4k)(408.1k)(188.8k)(3.6k)(12.9k)

Cash From Investing Activities

(11.2k)(167.4k)(483.1k)(188.8k)(3.6k)(12.9k)

Cash From Financing Activities

2.9m3.3m3.7m5.1m4.3m4.8m

Interest Paid

62.3k127.1k61.5k30.4k17.5k44.8k

BioRestorative Therapies Ratios

USDY, 2019

Financial Leverage

-0.3 x